Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial
Article in BMJ Open (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in BMJ Open (April 2024)
Article in The Lancet Respiratory Medicine (July 2023)
Article in Intensive Care Medicine Experimental (July 2022)